New Year Bumper Sale @ Rs. 1 X
Advog M 0.3 Tablet SR is a prescription drug, available for use as Tablet. The alternative uses of Advog M 0.3 Tablet SR have also been explained below.
Medical history of the patient along with age and gender determines the dosage of Advog M 0.3 Tablet SR. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. For detailed information on this, read through the dosage section.
Common side effects of Advog M 0.3 Tablet SR include Weakness, Headache, Nausea or vomiting. Apart from the aforementioned side effects, Advog M 0.3 Tablet SR can also lead to other problems, which have been listed below. Normally, these side effects of Advog M 0.3 Tablet SR are not long lasting and go away when the treatment is finished. Consult your doctor if these side effects become worse or stay for a longer duration.
Advog M 0.3 Tablet SR's effect during pregnancy is Severe and Severe while nursing. It is important to know if Advog M 0.3 Tablet SR has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Advog M 0.3 Tablet SR related warnings section.
Advog M 0.3 Tablet SR can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Advog M 0.3 Tablet SR in conditions like Diabetic Ketoacidosis.
Additionally, Advog M 0.3 Tablet SR may also adversely react with other medicines. See below for a complete list.
In addition to the above precautions for Advog M 0.3 Tablet SR, it is important to know that it is not safe while driving, and is not habit-forming.
Advog M 0.3 Tablet SR is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
Adult |
|
Geriatric |
|
Is the use of Advog M 0.3 Tablet SR safe for pregnant women?
Advog M shows severe side effect on pregnant women. For this reason, pregnant women should only take it after taking medical advice.
Is the use of Advog M 0.3 Tablet SR safe during breastfeeding?
Taking Advog M may lead to serious side effects if you are breastfeeding. Advog M should not be taken by breastfeeding women unless prescribed by the doctor.
What is the effect of Advog M 0.3 Tablet SR on the Kidneys?
There can be some harmful effects on your kidneys after taking Advog M. If you witness any side effects, discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Advog M 0.3 Tablet SR on the Liver?
You may experience side effects on your liver after taking Advog M. If this happens, then discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Advog M 0.3 Tablet SR on the Heart?
Side effects of Advog M rarely affect the heart.
Advog M 0.3 Tablet SR should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Advog M 0.3 Tablet SR unless your doctor advises you to do so -
Is this Advog M 0.3 Tablet SR habit forming or addictive?
Advog M 0.3 Tablet SR is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
After taking Advog M 0.3 Tablet SR you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Advog M 0.3 Tablet SR is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
Advog M 0.3 Tablet SR is unable to treat or cure mental disorders.
Interaction between Food and Advog M 0.3 Tablet SR
Due to the absence of research, it is difficult to say how Advog M 0.3 Tablet SR and food will interact.
Interaction between Alcohol and Advog M 0.3 Tablet SR
Due to lack of research, nothing can be said about side effects of consuming alcohol while taking Advog M 0.3 Tablet SR.
Take Advog M as advised by your doctor. It can be taken orally three times daily immediately before each meal. Precautions must be taken in patients with improper liver or kidney function.
Yes, Advog M can cause night sweat, the exact mechanism of sweating is not known. But some research suggests that it causes hypoglycemia (low blood sugar) especially at night which leads to night sweats. You need to monitor your blood glucose level regularly and talk to your doctor as your dose may need to be adjusted.
Yes, Advog M can cause low blood sugar (hypoglycemia). However, this can also occur if you delay or miss a meal, drink alcohol, exercise more than usual, can't eat due to stomach upset, and taking other antidiabetic medicine with voglibose. So, regular monitoring of blood glucose level is needed and be cautious of symptoms of hypoglycemia. It is best to consult your doctor if you feel any unwanted effects.
Advog M should be taken as long as needed or take it as directed by doctor. Do not discontinue the drug suddenly or take it longer than prescribed by your doctor.
Yes, Advog M is safe to use, if taken in prescribed amount and duration as advised by the doctor. However, certain side effects have been associated with this drug such as dizziness, nausea, and vomiting. If you experience any discomfort after taking this medicine then inform your doctor immediately and follow his/her instructions.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 277
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826